Nisa Investment Advisors’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.18M | Sell |
27,437
-4,667
| -15% | -$202K | 0.01% | 760 |
|
|
2025
Q1 | $1.11M | Buy |
32,104
+193
| +0.6% | +$6.67K | 0.01% | 795 |
|
|
2024
Q4 | $876K | Sell |
31,911
-142
| -0.4% | -$3.9K | ﹤0.01% | 905 |
|
|
2024
Q3 | $816K | Buy |
32,053
+175
| +0.5% | +$4.46K | ﹤0.01% | 904 |
|
|
2024
Q2 | $807K | Sell |
31,878
-7,069
| -18% | -$179K | 0.01% | 934 |
|
|
2024
Q1 | $1.2M | Sell |
38,947
-1,273
| -3% | -$39.4K | 0.01% | 823 |
|
|
2023
Q4 | $1.62M | Sell |
40,220
-3,200
| -7% | -$129K | 0.01% | 717 |
|
|
2023
Q3 | $1.14M | Sell |
43,420
-7,400
| -15% | -$195K | 0.01% | 831 |
|
|
2023
Q2 | $874K | Buy |
50,820
+1,270
| +3% | +$21.8K | 0.01% | 912 |
|
|
2023
Q1 | $822K | Buy |
49,550
+1,130
| +2% | +$18.7K | 0.01% | 919 |
|
|
2022
Q4 | $369K | Sell |
48,420
-2,292
| -5% | -$17.5K | ﹤0.01% | 1201 |
|
|
2022
Q3 | $505K | Buy |
50,712
+49,831
| +5,656% | +$496K | ﹤0.01% | 1025 |
|
|
2022
Q2 | $8K | Sell |
881
-50,800
| -98% | -$461K | ﹤0.01% | 2210 |
|
|
2022
Q1 | $525K | Sell |
51,681
-330
| -0.6% | -$3.35K | ﹤0.01% | 1063 |
|
|
2021
Q4 | $513K | Buy |
52,011
+44,453
| +588% | +$438K | ﹤0.01% | 1006 |
|
|
2021
Q3 | $354 | Buy |
7,558
+147
| +2% | +$7 | ﹤0.01% | 1225 |
|
|
2021
Q2 | $452 | Buy |
7,411
+1,200
| +19% | +$73 | ﹤0.01% | 1162 |
|
|
2021
Q1 | $383 | Buy |
6,211
+400
| +7% | +$25 | ﹤0.01% | 1246 |
|
|
2020
Q4 | $413K | Buy |
5,811
+3,001
| +107% | +$213K | ﹤0.01% | 1226 |
|
|
2020
Q3 | $105K | Buy |
2,810
+2,260
| +411% | +$84.4K | ﹤0.01% | 1530 |
|
|
2020
Q2 | $18K | Hold |
550
| – | – | ﹤0.01% | 1793 |
|
|
2020
Q1 | $16K | Buy |
+550
| New | +$16K | ﹤0.01% | 1756 |
|